Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes: Management and Pharmacotherapy

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Population Incidence and Burden of Juvenile Idiopathic Arthritis on Australian Health System: Data Linkage Study.

Journal of paediatrics and child health·2025

Same author

Cost effectiveness of dietitian-led nutrition therapy for people with type 2 diabetes mellitus: a scoping review.

Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2020

Same author

Successful implementation of diabetes audits in Australia: the Australian National Diabetes Information Audit and Benchmarking (ANDIAB) initiative.

Diabetic medicine : a journal of the British Diabetic Association·2018

Same author

Improvement in glycated haemoglobin evaluated by baseline body mass index: a meta-analysis of the liraglutide phase III clinical trial programme.

Diabetes, obesity & metabolism·2015

Same author

Cost to government and society of chronic kidney disease stage 1-5: a national cohort study.

Internal medicine journal·2015

Same author

Estimating insulin demand for protein-containing foods using the food insulin index.

European journal of clinical nutrition·2014

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Diabesity: therapeutic options.

¹Boden Institute of Obesity, Nutrition and Exercise, University of Sydney, Sydney, NSW, Australia. scolagiuri@usyd.edu.au

Diabetes, Obesity & Metabolism

|June 4, 2010

Summary

This summary is machine-generated.

Type 2 diabetes and obesity are linked, creating a global health crisis. This review explores therapies for both conditions, highlighting incretin-based treatments and bariatric surgery for improved outcomes.

More Related Videos

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Related Experiment Videos

Last Updated: Jun 12, 2026

Multidisciplinary Approach to Obesity Management: A Case Report

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

An Acupoint Catgut-embedding Therapy for Treating Obesity

An Acupoint Catgut-embedding Therapy for Treating Obesity

Published on: April 4, 2025

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Duodenal-Jejunal Bypass Surgery in Diet-Induced Obese Diabetic Mice

Published on: October 18, 2024

Area of Science:

Endocrinology and Metabolic Diseases
Public Health

Background:

Type 2 diabetes and obesity represent a significant global health crisis, with increasing prevalence linked to environmental factors like diet and physical activity.
Both conditions share a pathogenic relationship and independently increase the risk of severe comorbidities such as cardiovascular disease, hypertension, and stroke.

Purpose of the Study:

To examine the etiological links between type 2 diabetes and obesity.
To review current and emerging therapeutic strategies for managing both conditions concurrently.

Main Methods:

Analysis of recent clinical evidence on incretin-based antidiabetic therapies (DPP-4 inhibitors, GLP-1 receptor agonists).
Evaluation of antiobesity therapeutic strategies, including pharmacological agents, behavioral modification, and bariatric surgery (e.g., gastric banding, Roux-en-Y gastric bypass).

Main Results:

DPP-4 inhibitors offer weight-neutral to modest weight loss effects, while GLP-1 receptor agonists promote significant weight reduction.
Antiobesity agents like orlistat and sibutramine show high attrition rates and uncertain long-term efficacy.
Bariatric surgery demonstrates high type 2 diabetes remission rates, up to 73% for procedures like Roux-en-Y gastric bypass.

Conclusions:

Integrated therapeutic strategies addressing both glycemic control and weight loss are crucial for managing the rising prevalence of type 2 diabetes and obesity.
Incretin-based therapies and bariatric surgery show promise in managing these interconnected conditions.
Further research is needed to understand the long-term effects of antiobesity agents.